Mast Therapeutics CEO Robert Neville's 2019 pay falls 75% to $1M
Mast Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 15, 2020
Mast Therapeutics reported fiscal year 2019 executive compensation information on April 15, 2020.
In 2019, three executives at Mast Therapeutics received on average a compensation package of $919K, a 70% decrease compared to previous year.
Average pay of disclosed executives at Mast Therapeutics
Robert Neville, Chief Executive Officer, received $1M in total, which decreased by 75% compared to 2018. 52% of Neville's compensation, or $546K, was in salary. Neville also received $239K in non-equity incentive plan, $241K in option awards, as well as $22K in other compensation.
Taneli Jouhikainen, Chief Operating Officer, received a compensation package of $1M, which decreased by 74% compared to previous year. 54% of the compensation package, or $546K, was in salary.
David Lowrance, Chief Financial Officer, earned $699K in 2019, a 68% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 15, 2020.